Stay updated on Pembrolizumab for Head and Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Head and Neck Cancer Clinical Trial page.

Latest updates to the Pembrolizumab for Head and Neck Cancer Clinical Trial page
- Check4 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.2%
- Check12 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.0%
- Check19 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check26 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference0.4%
- Check33 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.1%
- Check40 days agoChange DetectedThe page has removed a detailed citation regarding a study on pembrolizumab and cetuximab for head and neck cancer, which is a significant loss of core content.SummaryDifference0.2%
Stay in the know with updates to Pembrolizumab for Head and Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Head and Neck Cancer Clinical Trial page.